Global cell separation market was valued at USD6.6 billion in 2020. It is expected to grow at a compound annual rate (CAGR), of 18.8% between 2021 and 2028. Cell separation is an essential part of many applications, including in-vitro diagnostics and biologics design and development. Market growth is largely driven by the rising incidence of chronic and infectious diseases like cancer and Covid-19. There are also continuous government initiatives to improve biotechnology industry.
Researchers have a great opportunity to understand and develop new treatments and diagnostic tools, thanks to the COVID-19 pandemic. Numerous pharmaceutical and biotech companies have engaged in rapid R&D to develop new vaccines, treatments, and testing tools. This has greatly boosted the need for cell separation tools for research applications.
For the development and production of biologics such as monoclonal antibodies or recombinant protein, cell separation and isolation techniques are used extensively. These products have gained popularity over the last few decades. The demand for biologics is increasing due to the significant growth in specialty drugs and personalized medicines. According to CAS, a division of American Chemical Society, biologics are expected to reach USD 399.5 billion in 2025. In the last few years, the number of biologics that have been registered under CAS has increased by three-hundredfold. Increasing regulatory convergence, technological advances in R&D, as well as an increase in chronic diseases, have all contributed to the increasing demand for biologics. Consequently, the growing demand for biologics will lead to a high demand for separation products during manufacturing, which is expected to support the growth of cell separation market.
The increasing prevalence of chronic diseases has also increased the need for cell separation solutions to aid in research and diagnostics. The American Cancer Society estimates that there will be 16.9 million survivors/patients of cancer in 2020. According to the same source, more than 1.8 million new cases will be diagnosed each year. According to WHO, 71.0 million people around the world will be living with chronic hepatitis C in 2020. According to the American Autoimmune Related Diseases Association, Inc., 50 million Americans were living with autoimmune diseases in 2017.
Cell separation instruments and other related products are useful tools in scientific research and diagnosis. This market is being held back by high prices for these products. Cell separation techniques can be expensive. They require instruments, reagents and kits. Cell separation setup can be expensive and reagents for certain applications can be costly. These factors will limit market growth during the forecast period.
The consumables segment was the dominant market for cell separation in 2020 and accounted for the highest revenue share at 62.3%. Because of the large number of consumables purchased, this segment held the largest market share. The segment is also being driven by rising investments in R&D at biopharmaceutical and biotechnology companies to develop advanced biologics, including monoclonal antibody vaccines and vaccines. The forecast period will see a high demand for consumables.
Due to product innovations, the instruments segment will experience a significant growth rate over the forecast period. Instrument technology has made it possible to efficiently separate cells in research, diagnostics and therapeutics. The industry for instruments is expected to experience significant growth over the forecast period. The market's growth will be impeded by the high cost instruments.
In 2020, the largest revenue share was held by the human cell segment which dominated cell separation market with 44.8%. Its largest share is due to the increasing focus on cancer and human research, as well as diverse applications of isolated human cells in biopharmaceuticals research, clinical trials, and drug development. Favorable reimbursement policies in developed countries for personalized medicine also contribute to the increase in demand for human cell isolate.
The segment of animal cells is expected to grow at a high rate over the forecast period. This is due to the increasing focus of healthcare, government and private companies on drug discovery and development. Drug discovery and development involves the use of animal cells to test efficacy, pharmacokinetics, and preliminary toxicities.
In 2020, the largest revenue share was held by the centrifugation segment which dominated cell separation market with 42.7%. This is due in large part to the widespread use of this technique by biotech and biopharmaceutical businesses, academic institutes, and research laboratories. One of the most critical steps in cell isolation is centrifugation. Cell isolation is most commonly achieved by differential centrifugation or density gradient centrifugation. Differential centrifugation uses a lysate to break down cell membranes, while density gradient centrifugation uses molecular weights.
In the near future, the filtration and surface marker segments will see significant growth. This segment is supported by significant growth due to increased investments by companies in manufacturing infrastructure and product improvements. For better quality products, manufacturers use advanced filtration system surface markings in production and research.
In 2020, the largest revenue share was 30.8% for the biomolecule isolation segment. Its highest share is due to the increasing focus on biopharmaceuticals including biosimilar, monoclonal and recombinant protein production. The market is also booming due to increased government funding for drug development.
Over the course of the study, both stem cell and cancer research will experience lucrative growth. The growth of the segment can be attributed to a rise in investment by research labs and companies in cell-based research. Due to increasing cancer incidence worldwide, a number of public-private entities are investing heavily in cancer research. This drives the need for innovative separation solutions.
Research laboratories and institutes accounted for 43.9% of the total revenue in 2020. It is expected to maintain its position through the entire study period. Research institutions are investing more in R&D to develop new therapies in neuroscience and oncology. This segment is expected to grow due to the increasing number of laboratories and research institutes around the world. The New York Stem Cell Foundation (NYSCF), for instance, opened a new Research Institute in Manhattan in April 2017. It is geared towards conducting the most advanced stem cells research.
Due to increased R&D investments by these companies in the development of new products, the biotechnology and pharmaceutical sector saw significant growth during the forecast period. These companies engage in extensive R&D activities to develop new-generation therapeutics. Cell separation techniques are required. Commercial organizations are expected to increase their research efforts to develop effective COVID-19 vaccines and therapeutics. This will support segment growth.
North America was the dominant market for cell separation and had the largest revenue share at 38.5% in 2020. This is due to the well-established biotech and pharmaceutical industries and the rapid adoption of technologically advanced products in the U.S. A large demand exists for cell separation products due to the extensive research conducted by universities in the field cell therapies. A rise in chronic and infectious diseases such as COVID-19 has also led to a greater demand for cell separation products for clinical and research purposes.
The Asia Pacific market for cell separation will see significant growth because of the growing biotech and pharmaceutical industries in emerging countries like India and China. The segment will be driven by factors such as the growth of healthcare spending and the increase in market penetration in key Asia Pacific countries. The demand for cell separation solutions has been boosted by ongoing stem-and gene therapy research in Japan, China, South Korea, and South Korea.
To gain high market share, key players are involved in both organic and inorganic growth strategies, such as collaborations, partnerships and mergers. In February 2021, Thermo Fisher Scientific purchased cell-sorting assets of Propel Labs, a U.S.-based company. The deal included the addition of Propel Labs' Bigfoot Spectral cell Sorter and 40 employees to Thermo Fisher Scientific. The following are some of the major players in the global cell separator market:
Thermo Fisher Scientific, Inc.
Becton, Dickinson and Company
Danaher
Beckman Coulter, Inc.
Cytiva
Up Market Research published a new report titled “Cell Separation Market research report which is segmented by Technique (Surface Marker, Filtration, Centrifugation), by Product (Consumables, Instruments), By Players/Companies Beckman Coulter Inc, Becton Dickinson and Company, Thermo Fisher Scientific Inc, Cytiva, DanaherBeckman Coulter IncCytiva”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Attributes | Report Details |
Report Title | Cell Separation Market Research Report |
By Technique | Surface Marker, Filtration, Centrifugation |
By Product | Consumables, Instruments |
By Companies | Beckman Coulter Inc, Becton Dickinson and Company, Thermo Fisher Scientific Inc, Cytiva, DanaherBeckman Coulter IncCytiva |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 244 |
Number of Tables & Figures | 171 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Technique (Surface Marker, Filtration, Centrifugation), by Product (Consumables, Instruments).
Cell Separation Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Cell Separation Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Cell Separation Market Report:
Some other reports from this category!